A rare case of peripartum cardiomyopathy: a multidisciplinary approach
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20250886Keywords:
Cardiac obstetrics, Peripartum cardiomyopathy, Cardiomegaly, HypertensionAbstract
Cardio obstetrics has emerged as an important multidisciplinary field that requires a team approach to the management of cardiovascular disease during pregnancy. Maternal heart disease complicates approximately 1% and 4% of pregnancies and accounts for up to 15% of maternal deaths. Multidisciplinary care in the antenatal period and during labour with continued surveillance extended through the puerperium along with contraceptive advise has been shown to enhance the chances of favourable outcome in these high-risk patients. Although heart disease is rare among pregnant women, it needs to be carefully managed in tertiary case sitting by a team of obstetrician. cardiologist and anaesthesiologist to obtain good maternal and fetal outcome.
Metrics
References
Mehta LS, Warnes CA, Bradley E, Burton T, Economy K, Mehran R, et al. Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American Heart Association. Circulation. 2020;141(23):884-903.
Nqayana T, Moodely J, Naidoo DP. Cardiac disease in pregnancy: cardiovascular topic. Cardiovascul J Afr. 2008;19(3):145-51.
Roos Hesselink J, Baris L, Johnson M, De Backer J, Otto C, Marelli A, et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC registry of pregnancy and cardiac disease (ROPAC). European Heart J. 2019;40(47):3848-55. DOI: https://doi.org/10.1093/eurheartj/ehz136
Mehta LS, Warnes CA, Bradley E. Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement from the American Heart Association. Circulation. 2020;141(23):904. DOI: https://doi.org/10.1161/CIR.0000000000000772
Asghar F, Kokab H. Evaluation and outcome of pregnancy complicated by heart disease. J Pakistan Medical Association. 2005;55(10):416.
Elkayam U, Goland S, Pieper PG, Silversides CK. High-risk cardiac disease in pregnancy: part II. J American College of Cardiol. 2016;68(5):502-16. DOI: https://doi.org/10.1016/j.jacc.2016.05.050
Kovacs AH, Harrison JL, Colman JM, Sermer M, Siu SC, Silversides CK. Pregnancy and contraception in congenital heart disease: what women are not told. J American College of Cardiol. 2008;52(7):577-8. DOI: https://doi.org/10.1016/j.jacc.2008.05.013
Balci A, Sollie-Szarynska KM, Bijl AG, Ruys TP, Mulder BJ, Roos-Hesselink JW, et al. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart. 2014;100(17):1373-81. DOI: https://doi.org/10.1136/heartjnl-2014-305597
Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the task force on the management of cardiovascular diseases during pregnancy of the European society of cardiology (ESC). European J. 2011;32(24):3147-97.
Fesslova VM, Villa L, Chessa M, Butera G, Salmona S, Acaia B. Prospective evaluation from single centre of pregnancy in women with congenital heart disease. International J Cardiol. 2009;131(2):257-64. DOI: https://doi.org/10.1016/j.ijcard.2007.10.030
Downloads
Published
How to Cite
Issue
Section
